Investors:
Reduce Risk and Increase returns
through direct access to
promising growth companies.
Learn More
Strategic Partners:
Achieve Your M&A And Licensing
Goals By Easily Connecting With
Compelling Growth Companies.
Learn More
Growth Companies:
Increase Access To Capital, Deal
Certainty And Likelihood of "Exit".
Learn More
- Investors, growth companies and strategic partners, together transforming global healthcare capital markets -
$350M+
Capital Raised
40
Companies Funded
27
Strategic Deals
$2.2B+
"Exit" Value

Successful Raises

During the past 12 months, Healthios clients have raised more than
$300 million in financing. Notable recent closings include:

Miacom Diagnostics develops molecular diagnostic kits. The company distributes rapid molecular diagnostic tests for...
$5,000,000
Offered
$5,000,000
Raised
Closed
Days Left
Funded: $5,000,000 of $5,000,000
100%
Clear Vascular is a medical pharmaceutical company that develops pharmaceutical products for the treatment of cardio...
$4,000,000
Offered
$4,000,000
Raised
Closed
Days Left
Funded: $4,000,000 of $4,000,000
100%
Wellfont is an institutional pharmacy that believes healthcare can be offered with higher quality and at lower cost...
$22,500,000
Offered
$22,500,000
Raised
Closed
Days Left
Funded: $22,500,000 of $22,500,000
100%
Dicerna is a biopharmaceutical company focused on the discovery and development of company focused on the discovery...
$60,000,000
Offered
$60,000,000
Raised
Closed
Days Left
Funded: $60,000,000 of $60,000,000
100%

Case Studies

Healthios has advised on more than 80 healthcare transactions in 15 countries, representing more than $2 billion in transaction value.

Has completed a $25,000,000 Series A Financing

Series A Investment in
"Series D" company

In The News